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The risk of complications of nonsurgical hypoparathyroidism in Asia is unclear. We esti-
mated the prevalence and risk of complications in patients with nonsurgical
hypoparathyroidism.
Methods
We performed a retrospective cohort study using a nationwide claims database from 2005
to 2016. Among the entire Korean population, we identified 897 patients diagnosed with
nonsurgical hypoparathyroidism during 2005–2015. We selected 210 patients with nonsur-
gical hypoparathyroidism during 2005–2008 who had no complications at baseline and fol-
lowed them to 2016. Control subjects (n = 2075) were matched using propensity scores
based on age, sex, and comorbid disease with a 1:10 ratio and monitored until 2016.
Results
The age-standardized prevalence of nonsurgical hypoparathyroidism was 0.2 cases per
100,000 persons in 2005. During a mean follow-up period of 9.5 years, patients with nonsur-
gical hypoparathyroidism had a higher risk of cardiovascular disease, especially arrhythmia
(hazard ratio [HR], 2.03; 95% confidence interval [CI], 1.11–3.70) and heart failure (HR,
2.43; 95% CI, 1.22–4.83). The risk of vertebral fracture was higher in patients than in con-
trols (HR, 2.27; 95% CI, 1.09–4.72). Patients had a significantly increased risk of renal dis-
ease (HR, 2.57; 95% CI, 1.56–4.21), seizure (HR, 5.74; 95% CI, 3.34–9.86), depression
and bipolar disease (HR, 1.82; 95% CI, 1.30–2.56), and cataract (HR, 1.90; 95% CI, 1.30–
2.79) compared with controls.
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Conclusions
The prevalence of nonsurgical hypoparathyroidism was very low in Korea but was associ-
ated with a higher risk of incident cardiovascular disease and vertebral fracture as well as
known complications including renal disease, seizure, and cataract.
Introduction
Hypoparathyroidism is a rare disease characterized by hypocalcemia with inappropriately low
parathyroid hormone (PTH) levels. Hypoparathyroidism can be divided into primary hypo-
parathyroidism due to intrinsic defects of the parathyroid glands, including genetic causes,
and a secondary form due to several causes including neck surgery, autoimmune disease, or
other rare infiltrative diseases [1]. Neck surgery is the most common cause of hypoparathy-
roidism (postsurgical hypoparathyroidism), accounting for approximately 75% of cases. Auto-
immune hypoparathyroidism is the next most common form in adults and may be isolated or
part of an autoimmune polyglandular syndrome. Worldwide, there are few reports on the
prevalence of nonsurgical hypoparathyroidism. The reported estimated prevalence has varied
among studies and is reported to be 0.7/100,000 persons in Japan and 2.3/100,000 persons in
Denmark [2,3]. Another study reported a prevalence of 4.8/100,000 persons in the United
States [4].
Although the U.S. Food and Drug Administration approved recombinant human PTH (1–
84) for managing hypoparathyroidism, high-dose calcium and active vitamin D has been the
main hypoparathyroidism treatment in most countries, generating concerns for unwanted
complications of hypercalciuria, renal stones, impaired renal function, and cardiovascular dis-
ease (CVD) [1].
To date, there has been no report on the risk of complications of nonsurgical hypoparathy-
roidism in Asia. Herein, we estimated the crude prevalence of nonsurgical hypoparathyroid-
ism in Korea using a large claims database. We also assessed the risks of complications and
mortality of patients with nonsurgical hypoparathyroidism compared with age-, sex-, and
comorbidity-matched controls. To the best of our knowledge, this is the first matched cohort
study using a nationwide database performed in Asia.
Materials and methods
Data source and study population
The National Health Information Database (NHID) is a public database on healthcare utiliza-
tion, health screening, sociodemographic variables, and mortality for the entire population of
South Korea, formed by the National Health Insurance Service [5]. The NHID contains pre-
scription drugs and treatment claims records for nearly all Koreans. From among 50 million
people in the NHID, we identified patients with nonsurgical hypoparathyroidism from 2005
through 2016. First, we identified patients with nonsurgical hypoparathyroidism based on the
International Classification of Diseases 10th revision (ICD 10) codes (D82.1, E20.0, E20.8,
E20.9, E31.0, E31.8, and E31.9) and at least two prescriptions for active vitamin D analogs.
Next, we excluded subjects who had a history of head and neck cancer, thyroid or parathyroid
surgery, radiation to the neck region, or stage 5 chronic kidney disease during 2002–2016. We
further excluded subjects who had renal insufficiency within 3 years before and within 1 year
after the index date to rule out secondary hypocalcemia due to renal insufficiency. We also
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excluded infants who were followed up<1 year after the index date to exclude neonatal tran-
sient hypoparathyroidism.
To examine the risks of complications and mortality of nonsurgical hypoparathyroidism,
we compared the prevalence of complications and mortality in a nonsurgical hypoparathyroid-
ism group and a control group. First, as case subjects, we selected 392 patients with newly diag-
nosed nonsurgical hypoparathyroidism during 2005–2008. After excluding 155 patients who
had complications within 3 years before the index date and 26 patients who were followed up
for<12 months, 211 patients with nonsurgical hypoparathyroidism were selected as cases.
The control population consisted of participants who did not have ICD codes of nonsurgical
hypoparathyroidism or any prescription of active vitamin D analogs. The exclusion criteria for
controls were the same as for cases. Control subjects were then selected from the control popu-
lation using 1:10 propensity score matching with the cases, which consisted of 2,075 subjects.
Variables for constructing the propensity scores were age, sex, and comorbid disease of either
diabetes or hypertension. Dyslipidemia was not used as a matching variable owing to its very
low frequency; however, it was adjusted for use in a subsequent multivariable model. All sub-
jects were followed up until December 31, 2016 using the NHID or until the subject’s death,
which was ascertained from the Resident Register of Korea [6]. This study was approved by
the Institutional Review Board of the Catholic Kwandong University, Republic of Korea (IRB
No. CKU-IRB050). As this study was based on the NHID, the Institutional Review Board did
not require informed consent from individual subjects. Data were fully anonymized and de-
identified for the analysis.
Comorbid disease and complications of nonsurgical hypoparathyroidism
Comorbid disease included diabetes mellitus, hypertension, and dyslipidemia. The diagnoses
of these diseases were determined according to ICD-10 codes and prescriptions of correspond-
ing medications for each disease: diabetes (E10-E14), hypertension (I10-I15), and dyslipidemia
(E78). Any diagnosis of a complication during 2006–2016 was considered an incident episode
in both groups. Complications were selected using three- or four-digit ICD-10 codes as fol-
lows: ischemic heart disease (I20, I24, I25), acute myocardial infarction (I21-I23), arrhythmia
(I44-I45, I47-I49), heart failure (I50), cerebral infarction (I61-I64, I67.9), renal stones
(N20-N23), renal insufficiency (N18-N19), seizure (G40-G41), cataract (H25, H26, H28.1),
depression and bipolar disease (F30-F34), fracture (S52.5, S52.6, S42.2, S42.3, S72.0, S72.1,
S22.0, S22.1, S32.0, M48.4, M48.5), and intracranial calcification (G23.8)
Statistical analysis
Baseline demographic and clinical characteristics of patients are summarized as median (mini-
mum-maximum) or mean (SD) for continuous variables and as number (percent) for categor-
ical variables. Prevalence was age-standardized to the 2010 Korean population based on the
2010 National Census of Statistics Korea and expressed per 100,000 persons. The 1:10 propen-
sity scores for matching cases to controls were made using a caliper width of 0.2 of the SD of
the logit of the propensity score. Considering matched data, a stratified multiple Cox propor-
tional hazards regression analysis was performed to determine significant complications of
nonsurgical hypoparathyroidism. Adjusted hazard ratios (HRs) and their 95% confidence
intervals (CIs) were calculated.
All analyses were performed using SAS software version 9.4 (SAS Institute, Cary, NC) and
STATA software version 15.0 (Stata Corp., College Station, TX), and a two-sided P< 0.05 was
considered statistically significant.
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Results
Prevalence, incidence, and clinical characteristics of nonsurgical
hypoparathyroidism
A total of 897 patients with nonsurgical hypoparathyroidism were identified from 2005
through 2015. The age-standardized prevalence of nonsurgical hypoparathyroidism was 0.2
cases per 100,000 persons in 2005 and 1.1 cases per 100,000 persons in 2015. The crude inci-
dence of nonsurgical hypoparathyroidism was 0.18 cases per 100,000 person-years in 2005 and
0.13 cases per 100,000 person-years in 2015. The clinical characteristics of the 897 patients
with nonsurgical hypoparathyroidism are shown in Table 1. The mean (± standard devidation)
age was 43.8 ± 21.9 years, and 59% of patients were female. Four percent of patients were diag-
nosed with DiGeorge syndrome. Among 897 patients, 504 (56%) had no complications of non-
surgical hypoparathyroidism at the time of their diagnosis. The prevalence of seizure, cataract,
depression and bipolar disease, and CVD at baseline was more than 10% in all patients.
Complications and mortality of nonsurgical hypoparathyroidism
After propensity score matching, the baseline characteristics of both groups were well
balanced (Table 2). None of the subjects had any complications at baseline. During a
median follow-up period of 9.5 years, the prevalence of any complication was higher in the
nonsurgical hypoparathyroidism cases than in the controls (52.4% vs. 30.3%; HR, 2.14; 95%
Table 1. Clinical characteristics of all patients with nonsurgical hypoparathyroidism from 2005 through 2015
(n = 897).
Variable Number (% or range)a
Female sex 529 (59%)
Age at baseline, years, mean (SD) 43.8 (21.9)
Diagnosis (code), n (%)
DiGeorge syndrome (D82.1) 36 (4.0%)
Autoimmune polyglandular failure (E31.0) 1 (0.1%)
Idiopathic or unspecified hypoparathyroidism (E20.0, E20.8, E20.9) 860 (95.9%)
Medication, median dose (min-max)
Vitamin D analogs, μg/day
Calcitriol only (n = 482) 0.25 (0.25–1.0)
Alfacalcidol only (n = 259) 0.5 (0.5–2.0)
Calcifediol only (n = 6) 20 (20–20)
Mixed (n = 150) NE
Calcium supplements
Elemental dose, mg/day 207 (100–1487)
Complications at baseline, n (%) 393 (43.8%)
Cardiovascular disease 139 (15.5%)
Renal stones 9 (1.0%)
Seizures 148 (16.5%)
Cataract 100 (11.2%)
Depression and bipolar disease 125 (13.9%)
Fracture 25 (2.8%)
Intracranial calcification 4 (0.5%)
NE, not evaluable.
https://doi.org/10.1371/journal.pone.0232842.t001
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CI, 1.74–2.62; P< 0.0001) (Table 3). However, the risk of mortality in the case group was not
significantly increased compared with that in the control group (HR, 1.56; 95% CI, 0.86–2.84;
P = 0.145)
Table 2. Baseline characteristics of patients with nonsurgical hypoparathyroidism and control group.
Variables Cases (n = 210) Controls (n = 2,075) P-valuea
Age, mean (SD) 39.2 (19.9) 39.2 (19.9) 0.408
Female sex 131 (62.4) 1,299 (62.6) 0.813
Case enrollment year
2005 49 (23.3) 465 (22.4)
2006 59 (28.1) 590 (28.4)
2007 59 (28.1) 590 (28.4)
2008 43 (20.5) 430 (20.7)
Comorbidities
Diabetes 5 (2.4) 30 (1.5) 0.424
Hypertension 34 (16.2) 289 (13.9) 0.284
Dyslipidemia 3 (1.4) 5 (0.2) NE
NE, not estimated due to low frequency.
Values given are number (%) unless indicated otherwise.
aP-values were obtained using a generalized estimating equation for matched data.
https://doi.org/10.1371/journal.pone.0232842.t002
Table 3. Complications following nonsurgical hypoparathyroidism.
Cases (n = 210) Controls (n = 2,075) aHR (95% CI) P-value
Any complications 110 (52.4) 629 (30.3) 2.14 (1.74–2.62) <0.0001
CVD
IHD 14 (6.7) 126 (6.1) 1.04 (0.60–1.79) 0.902
AMI 2 (1.0) 10 (0.5) 2.03 (0.41–9.93) 0.384
Arrhythmia 13 (6.2) 63 (3.0) 2.03 (1.11–3.70) 0.021
Heart failure 9 (4.3) 38 (1.8) 2.43 (1.22–4.83) 0.012
Cerebral infarction 11 (5.2) 77 (3.7) 1.47 (0.79–2.73) 0.223
Any CVD 39 (18.6) 171 (8.2) 1.64 (1.20–2.26) 0.002
Renal complications
Renal stones 10 (4.8) 46 (2.2) 2.13 (1.10–4.13) 0.025
Renal insufficiency 9 (4.3) 27 (1.3) 3.44 (1.63–7.23) 0.001
Any renal complication 18 (8.6) 71 (3.4) 2.57 (1.56–4.21) 0.0002
Seizures 17 (8.1) 31 (1.5) 5.74 (3.34–9.86) <0.0001
Cataract 32 (15.2) 179 (8.6) 1.90 (1.30–2.79) 0.001
Depression and bipolar disease 44 (21.0) 258 (12.4) 1.82 (1.30–2.56) 0.0006
Fracture
Humerus or wrist fracture 7 (3.3) 71 (3.4) 0.92 (0.42–2.01) 0.836
Vertebral fracture 9 (4.3) 39 (1.9) 2.27 (1.09–4.72) 0.029
Hip fracture 0 (0.0) 11 (0.5) NE
Any fracture 15 (7.1) 116 (5.6) 1.26 (0.73–2.16) 0.404
Intracranial calcification 2 (1.0) 0 (0.0) NE
Death 13 (6.2) 81 (3.9) 1.56 (0.86–2.84) 0.145
aHR, adjusted hazard ratio; AMI, acute myocardial infarction; CI, confidence interval; CVD, cardiovascular disease; IHD, ischemic heart disease; NE, not evaluable.
Values given are number (%) unless indicated otherwise. The aHR (95% CI) and P-values were obtained using a stratified Cox proportional hazards regression analysis.
https://doi.org/10.1371/journal.pone.0232842.t003
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Cardiovascular disease. Overall, the risk of any CVD event was significantly increased in
patients with nonsurgical hypoparathyroidism compared with controls during the follow-up
period (HR, 1.64; 95% CI, 1.20–2.26, P = 0.002) (Table 3). This was because of a significantly
increased risk of heart failure (HR, 2.43; 95% CI, 1.22–4.83; P = 0.012) and arrhythmia (HR,
2.03; 95% CI, 1.11–3.70; P = 0.021) in the patient group (Fig 1). The risk of ischemic heart dis-
ease and cerebral infarction did not differ between the groups.
Fractures. There was no difference in the prevalence of any type of fracture between the
groups (7.1% for cases vs. 5.6% for controls, P = 0.404). However, the risk of vertebral fracture
was higher in the case group than in the control group (HR, 2.27; 95% CI, 1.09–4.72;
P = 0.029) (Table 3).
Other complications. The risk of any renal complication was higher in the case group
than in the control group (HR, 2.57; 95% CI, 1.56–4.21; P = 0.0002) (Table 3). Specifically, the
risk of renal insufficiency was approximately three times higher in patients than in controls
(HR, 3.44; 95% CI, 1.63–7.23; P = 0.001) and the risk of renal stones was higher in the case
group (HR, 2.13; 95% CI, 1.10–4.13; P = 0.025). Patients with nonsurgical hypoparathyroidism
had a higher risk of seizure than did controls (HR, 5.74; 95% CI, 3.34–9.86; P< 0.0001). The
prevalence of cataract was significantly higher in the case group than in the control group
(HR, 1.90; 95% CI, 1.30–2.79; P = 0.001). Furthermore, the case group had a higher prevalence
of depression and bipolar disease than did controls (HR, 1.82; 95% CI; 1.30–2.56; P = 0.0006).
Discussion
Principal findings
Our study represents a large-scale assessment of nonsurgical hypoparathyroidism using a well-
documented nationwide database. In this propensity-weighted cohort study, patients with
nonsurgical hypoparathyroidism had an increased risk for CVD and vertebral fracture as well
as known complications of hypoparathyroidism such as renal disease compared with controls.
Regarding CVD, the risk of arrhythmia and heart failure was significantly increased in patients
with nonsurgical hypoparathyroidism.
Fig 1. Kaplan-Meier survival curve of arrhythmia (A) and heart failure (B) in patients with nonsurgical hypoparathyroidism and controls. Hazard ratios (HRs) with
95% confidence intervals (CIs) are shown.
https://doi.org/10.1371/journal.pone.0232842.g001
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Interpretation and differences in relation to other studies
Worldwide, reports on the prevalence of nonsurgical hypoparathyroidism are rare. Nakamura
et al. reported that the total number of patients with nonsurgical hypoparathyroidism was 900,
for an estimated prevalence of 0.7/100,000 persons, in Japan [2]. Recently, Underbjerg et al.
assessed the prevalence and complication risk of nonsurgical hypoparathyroidism using data
from the Danish National Patient Registry and estimated its prevalence to be 2.3/100,000 per-
sons [3]. We noted that the prevalence of age-standardized nonsurgical hypoparathyroidism
was 1.1/100,000 persons in Korea.
Hypocalcemia can cause QT prolongation and induce arrhythmias [7]. Dilated cardiomy-
opathy and heart failure are known but rare complications of chronic hypocalcemia in patients
with hypoparathyroidism, as described in a few case reports [8–11]. To date, few longitudinal
cohort studies have investigated the risk of CVD including heart failure in patients with hypo-
parathyroidism. Our study found that the risk of heart failure was 2.4-fold higher in patients
with hypoparathyroidism than in controls during 9.5 years of follow-up (4.3% vs. 1.8%). It was
previously reported that the prevalence of heart failure in the general population was 1.5% in
Korea, indicating that our result regarding the prevalence of heart failure is reliable [12]. Some
plausible mechanisms exist to explain the increased risk of heart failure in patients with hypo-
parathyroidism. Calcium is an essential component for cardiac muscle contraction, and hypocal-
cemia has been shown to reduce cardiac contractility [13]. In hypoparathyroidism, serum
calcium levels are preferentially maintained in the low-normal range or slightly below the nor-
mal range. Therefore, some patients treated with calcium and active vitamin D may have mild
chronic hypocalcemia, which contributes to the increased risk of heart failure. It was also
reported that vitamin D and PTH may have independent roles in cardiac function. Many studies
have shown that there was a strong association between vitamin D deficiency and heart failure.
Furthermore, vitamin D receptor knockout mice showed deterioration of heart function and
accelerated myocardial remodeling [14,15]. It has been shown that PTH acts on voltage-gated
calcium channels and exerts a positive chronotropic effect in neonatal cardiomyocytes [16]. In
contrast, Mitchell et al. reported that one patient (0.8%) of 120 patients with hypoparathyroidism
had dilated cardiomyopathy during 7.4 years of follow-up [17]. In another Danish cohort study,
patients with nonsurgical hypoparathyroidism had an increased risk of CVD due mainly to
ischemic heart disease and arrhythmia, but heart failure was not examined in this study [3].
Patients with chronic hypoparathyroidism have reduced bone remodeling, resulting in
higher bone mass than age- and sex-matched controls [17–19]. However, few studies have
reported a fracture risk in chronic hypoparathyroidism, and results have been inconsistent.
Underbjerg et al. [3] found an increased risk of fracture of the forearm or proximal humerus
(approximately 2.8-fold) in patients with nonsurgical hypoparathyroidism compared with
controls, whereas the overall risk of fracture, including vertebral fracture, was similar between
the hypoparathyroidism case and control groups. Our study did not show an increased risk of
any fracture in patients with nonsurgical hypoparathyroidism, although the risk of vertebral
fracture was two times higher in patients than in controls. Two small studies have investigated
the risk of vertebral fracture in patients with postsurgical hypoparathyroidism. One study
demonstrated that patients with hypoparathyroidism had more morphometric vertebral frac-
tures than in age- and body mass index-matched controls [20], whereas another study found
that patients with hypoparathyroidism had a lower incidence of spine deformity than controls
[21]. Recently, Chawla et al. reported that patients with idiopathic hypoparathyroidism had a
higher prevalence of morphometric vertebral fracture (odds ratio, 4.54; 95% CI, 1.28–16.04),
although the bone mineral density of lumbar spine was significantly higher by 21.4% in
patients with hypoparathyroidism than in controls [22]. Furthermore, they noted that the
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prevalence of vertebral fracture was greater in patients with hypoparathyroidism, especially in
postmenopausal women and those on anticonvulsant therapy. Therefore, monitoring for ver-
tebral fracture through lateral radiography of the spine and examination of clinical risk factors
for fracture may be warranted in patients with nonsurgical hypoparathyroidism. To date, the
long-term effects of low bone turnover and increased bone mass on fracture risk in chronic
hypoparathyroidism remain unclear and need to be assessed further.
Generally, PTH stimulates renal tubular reabsorption of calcium. Therefore, hypoparathy-
roidism itself may increase the risk of hypercalciuria, and treatment with large doses of cal-
cium supplements and active vitamin D can also increase the risk of hypercalciuria, renal
stones, and renal insufficiency in hypoparathyroidism [1]. In our study, patients with nonsur-
gical hypoparathyroidism had a 2-fold increased risk of renal stone and a more than 3-fold
increased risk of renal insufficiency compared with the general population (or control sub-
jects). In the Danish cohort study, patients with nonsurgical hypoparathyroidism had a signifi-
cantly increased risk of renal insufficiency (HR, 6.01; 95% CI, 2.45–14.75) but not an increased
risk of nephrolithiasis (HR, 0.80; 95% CI, 0.17–3.85) [3].
Cataract is a frequent manifestation of chronic hypoparathyroidism. A low PTH level in
hypoparathyroidism induces high phosphate levels, and treatment with high-dose calcium and
active vitamin D may increase the calcium-phosphate product, which can induce calcium-phos-
phate crystal formation in the lens of the eyes [23]. In the Danish cohort study, patients with non-
surgical hypoparathyroidism had an increased risk of cataract (HR, 4.21; 95% CI, 2.13–8.34)
compared with controls, similar to our result. However, another Danish study of postsurgical
hypoparathyroidism showed no difference in the risk of cataract between patients and controls.
It is not clear whether nonsurgical hypoparathyroidism increases the risk of psychiatric dis-
order. In this study, the risk of depression and bipolar disease was increased in patients with
nonsurgical hypoparathyroidism, which is consistent with findings from previous studies. One
previous Danish case-control study found that neuropsychiatric complications were more
prevalent in patients with nonsurgical hypoparathyroidism than in controls (HR, 2.45; 95%
CI, 1.78–3.35). Furthermore, some studies showed an increased risk of depression and anxiety
as well as an impaired quality of life in patients with hypoparathyroidism [24–26].
Strengths and weaknesses
This study has several strengths and weaknesses. We used the NHID, which covers nearly the
entire Korean population with a sample size of over 50 million. Therefore, our study captured
nearly all patients with nonsurgical hypoparathyroidism in Korea and is the first large-scale study
determining the prevalence and complications of nonsurgical hypoparathyroidism in Korea. The
main limitation was that the information regarding the diagnosis of disease may not be optimal
for identifying disease prevalence, as the data were not established for research purposes. There-
fore, we added prescription data as a secondary criterion of diagnosis and used several exclusion
variables to improve the accuracy of diagnosis. Additionally, because we did not perform medical
chart reviews, we could not assess the exact dose of calcium supplements and active vitamin D
analogs. Another limitation was the lack of biochemical data such as serum calcium levels at base-
line and during the follow-up period. Finally, our findings were limited by potential residual and
unrecognized confounding bias, even though we performed propensity score matching.
Conclusion
Nonsurgical hypoparathyroidism is associated with an increased risk of heart failure and verte-
bral fracture as well as previously well-known complications such as renal stones and cataract.
Careful screening is needed for long-term complications of nonsurgical hypoparathyroidism.
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